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Abstract
Limited data exist regarding the evaluation and selection of older candidates for trans-
plantation. To help guide the development of program protocols and help define re-
search questions in this area, we surveyed U.S. transplant centers regarding their 
current practices in the evaluation of older kidney transplant candidates. We emailed 
a 28- question survey to the medical and surgical directors of 190 adult kidney trans-
plant programs in the USA. We received usable responses from 59 programs, a 31.1% 
response rate. Most (76.3%) programs do not have absolute age cutoffs for listing 
patients, but for the 22.0% of programs that do have cutoffs, the mean age was 79, 
range 70- 90. Nearly one- third (29.2%) of programs require a minimum life expectancy 
to list for transplant, reporting a mean of 4.5 years life expectancy, (range 2- 10). 
Programs vary significantly in evaluating candidates living in a nursing home or with 
cognitive impairments. Practices regarding the evaluation of older transplant candi-
dates vary widely between U.S. programs. Further studies are needed on the impact of 
age and other comorbidities on transplant outcomes, to help guide decisions on which 
older patients are most appropriate for transplant listing.
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1  | INTRODUCTION
As the U.S. population continues to live longer, and the number of older 
patients listed for kidney transplantation continues to increase,1,2 deci-
sions about which patients to exclude from listing have become increas-
ingly common. Older recipients generally have more cardiovascular and 
other comorbidities, including cognitive and functional impairments. As 
a result, most1,3 although not all4 studies have shown that older re-
cipients have worse graft and patient outcomes than younger recipi-
ents. However, many studies have demonstrated that older recipients 
have better survival with kidney transplantation than with dialysis5-7 
although depending on patient selection, this is not always the case.8 
Where exactly to draw the line in accepting candidates for transplan-
tation continues to be challenging. While some predictive models as 
to which older candidates would benefit have been proposed,9,10 a 
consensus conference in 2012 on solid organ transplantation in older 
adults noted how few studies have addressed these issues.11
Documenting current practices in the evaluation of older candi-
dates is an important step in guiding the development of program pro-
tocols and helping define research questions in this area. To this end, 
we surveyed U.S. transplant centers regarding their current practices 
in the evaluation of older kidney transplant candidates.
2  | MATERIALS AND METHODS
We designed a 28- question web- based survey to obtain information 
on practices regarding the evaluation of elderly candidates for kidney 
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transplantation. We purchased from UNOS a list of medical and surgi-
cal directors from all 222 kidney transplant programs, and excluded 
the 30 pediatric- only programs. Because UNOS does not provide 
e-mail addresses, we searched the Internet and called transplant cent-
ers to obtain the current e-mail addresses of the medical or surgical 
director. We were unable to obtain email addresses for two programs. 
We then sent to 190 programs an email describing the study along 
with a secured hyperlink to complete the online survey. The email 
was sent three times between 5/3/13 and 6/19/13, with only pro-
grams who had not responded receiving repeat requests to answer. 
We asked respondents to provide their UNOS program code, so we 
could track whether multiple responses were received from a particu-
lar program. For the two program that had two respondents, we used 
the medical director’s responses in the statistical analyses. We used 
the RedCap survey manager to send emails and manage responses. 
All answers were kept anonymous. Survey responses were coded and 
downloaded into Statistical Package for the Social Sciences Version 
19 (IBM Corp., Armonk, NY, USA) for analysis.
Data are expressed as median, mean and SD, or the percentage 
of centers with specific responses. Survey responses were examined 
by respondent age (median split), respondent specialty (nephrologist 
vs. surgeon), program patient volume (median split), and percent-
age	 of	 transplant	 recipients	 ≥65	year	 old	 (median	 split).	 Analyses	
included t-tests for continuous variables, Fisher’s exact test for 
variables with two categories, or a two- tailed chi- squared test for 
variables with three or more categories. A Bonferroni correction was 
made for multiple comparisons to determine statistical significance.
3  | RESULTS
3.1 | Respondent demographics
Of the 190 programs surveyed, we received responses from 67 
(35.3%). Six surveys were returned with no answers, and for two 
programs, both a nephrologist and surgeon returned surveys, so only 
the nephrologist’s answers were used in our analysis. Therefore, our 
effective response rate was 59/190 or 31.1%. Respondents were 
50.9% nephrologists, 43.4% surgeons, and 5.7% other positions. 
Because the survey questions relate to age, we asked respondents 
their own age: the median age was 51, mean 51.5 (±8.63), and range 
36- 71. The number of kidney transplants performed in 2012, not in-
cluding combined organs, was a median 80, mean 108.5 ± 77.5, range 
21- 350.
The	reported	percentage	of	kidney	transplant	recipients	≥65	years	
old is shown in Figure 1. The median percentage of recipients 
≥65	years	old	was	20%,	mean	23	±	11.4%,	with	a	very	wide	range	of	
older recipients, 3%- 50% of transplants. The reported percentage of 
waitlisted	patients	≥65	years	old	was	median	25%,	mean	23.9	±	9.8%,	
range	7.5%-	50%.	The	slightly	higher	proportion	of	patients	≥65	years	
old on the waitlist compared to those receiving transplants likely re-
flects the lower likelihood of transplantation for older patients. All 
UNOS regions were represented among respondents, with % of total 
responses (n = 54) ranging from 5.6% from region 3, to 16.7% from 
region 2.
3.2 | Practices regarding listing of older patients
When asked about the transplant program’s upper age cutoff for list-
ing a patient for kidney transplantation (n = 59), 76.3% (n = 45) re-
ported having no cutoff and 1.7% (n = 1) reported another policy. The 
22.0% (n = 13) of programs with a specific cutoff reported an upper 
age limit ranging from 70 to 90 years old, with a median of 80 and 
mean 79 ± 5.5 years old. Of the respondents with no overall cutoff 
for listing, a number of programs reported having age limits for listing 
patients with specific comorbidities, the most common being heart 
disease (Figure 2).
We also asked whether programs have a cutoff for listing trans-
plant candidates based on life expectancy without transplant. Of the 
59 responders, 50.8% reported no cutoff policy, but for the remain-
ing 49.2%, the years of life expectancy required to list ranged from 
2 to 10, with a mean of 4.5 ± 1.7 and median of 5. In a separate 
question about listing candidates expected to only benefit from 
F IGURE  1 What percentage of your 
kidney	transplant	recipients	are	≥65	years	
old? n = 49
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transplantation in terms of quality of life, but not length of life, most 
(61% of n = 58) reported that they would list such candidates, while 
25.4% would not.
The next series of questions related to impairments sometimes 
found in older transplant candidates. When asked about listing can-
didates who live in a nursing home (Figure 3), the most common 
practice is to exclude them from listing (41.4%), but the second most 
common response (24.1%) was that nursing home residency is not 
a factor for acceptance. Other programs would accept candidates 
based on specific reasons for nursing home residency. Cognitive 
impairment was not necessarily a reason for exclusion (Figure 4), 
with the most common response being that candidates would be 
excluded only if cognitive impairment was accompanied by lack of 
good supports to ensure compliance (72.9%). A minority of programs 
would use cognitive impairment as a listing exclusion only if the im-
pairment was expected to be progressive or if the impairment was 
“significant.” When asked whether a formal cognitive assessment 
is part of the routine transplant evaluation, 16.9% of programs re-
ported “always” while 69.5% answered that a formal assessment is 
only performed when informal assessments suggests doing so. Only 
one program (1.7%) reported performing formal assessments based 
on an age cutoff (75 years old). When programs were asked about 
accepting candidates with functional impairment (Figure 5), the an-
swers were similar to those about cognitive impairment, with most 
programs (61%) excluding candidates only if the candidate also does 
not have good supports, or the impairment was expected to be pro-
gressive (32.2%). The approach to formal functional assessments 
is similar to that for formal cognitive assessments, with 25.4% of 
programs always performing a functional assessment as part of the 
transplant evaluation, and 59.3% doing the functional assessment if 
informal assessments suggested doing so. Almost all programs have 
the same psychosocial evaluations of candidates based on age (96.6% 
of n = 58) and have the same upper age policy based on sex (96% of 
n = 57) and race/ethnicity (94.9% of n = 59).
To assess the interaction between living donation and listing of 
older transplant candidates, we asked programs about upper age cut-
offs to accept living donors; 83.5% of programs do not have an age 
cutoff for patients to receive a live donor kidney, but of the 13.8% 
(n = 8) that do have a cutoff, the mean age was 75 ± 8.5, range 60- 85. 
One program (1.7%) reported that the cutoff depends on the donor 
relation. When asked whether a nondirected live donor would be ac-
cepted for an older recipient, 78.6% of 58 respondents said yes, while 
8.9% would not accept a nondirected donor above an age cutoff rang-
ing from 60 to 70, mean 68 ± 4.5.
F IGURE  2  If your program has no 
upper age cutoff for listing, does it have an 
age cutoff that applies to listing potential 
recipients with specific medical conditions 
(choose all that apply)? n = 46
F IGURE  3 Does your program accept 
potential recipients who live in a nursing 
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3.3 | Waitlist management
Several additional questions were asked regarding waitlist management. 
Most programs (88.1%, n = 52) do not have an upper age cutoff for de- 
listing a potential kidney transplant recipient who was previously listed. 
However, 8.5% (n = 5) of respondents do report having an age cutoff for 
delisting, ranging from 75 to 85, mean 79 ± 4.2. While delisting based on 
age is even less common than denying the initial listing based on age, the 
presence of various comorbidities is commonly cited as a reason to de- 
list older candidates (Figure 6). The most common reported frequency 
of re- evaluation of waitlisted patients (n = 58) was yearly (51.8%), with 
every two years (8.9%) and every six months (7.1%) being much less 
common practices. A substantial proportion (30.4%) responded with 
“other policy,” including comments that the re-evaluation frequency de-
pends on comorbidities and distance from the top of the list, such that 
evaluations would be repeated when candidates approached the top.
When asked whether re- evaluations of waitlisted candidates are 
more frequent if they are older (n = 55), 60.0% of programs said no, 
while 36.4% responded yes, with an age cutoff ranging from 60 to 
70, mean 65.8 ± 4. Similarly, the frequency of repeat cardiac testing 
(n = 58) usually does not depend on age (65.5%), but 29.3% do perform 
more frequent testing, using an age cutoff ranging from 50- 70, mean 
59.2 ± 7.6 years old. When asked “if a high quality kidney from a young 
deceased donor is available, will you ever skip an older potential recip-
ient who is at the top of the list, to give the kidney to someone who is 
younger (n = 57), most respondents said no (71.9%), but 12.3% said 
yes, with an age cutoff ranging from 60 to 70, mean 65 ± 7.1 years old.
In addition to the above descriptive statistics, we analyzed the re-
sponses to see whether we could detect any patterns of different an-
swers based on (i) respondent age, (ii) nephrology or surgical position, 
(iii) size of program, and (iv) higher or lower percentage of transplant 
recipients	 ≥65	years	 old.	 We	 did	 not	 detect	 any	 statistically	 signifi-
cant differences in answers based on any of these four respondent 
characteristics.
4  | DISCUSSION
In areas of medicine with high quality detailed data to guide decision- 
making, practices tend to be relatively uniform among different 
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providers. However, in the absence of good data, practices vary sig-
nificantly. Given the limited data to guide U.S. transplant centers in 
the evaluation and selection of older candidates in listing for kidney 
transplantation, it is not surprising for us to find that practices dif-
fer greatly between centers. The results of our survey demonstrate 
a wide range in the percentage of over 65 year olds receiving kidney 
transplants, from 3% to 50%. These differences may partly reflect dif-
ferences in local demographics, but also reflect widely different ap-
proaches to accepting these older patients.
In general, programs are hesitant to use absolute chronological 
cutoffs (76.3% of programs), but if they decide to do so, they pick a rel-
atively high cutoff (median 80 years old). This approach likely reflects 
that used in many other areas of medicine, in that “physiological” age is 
considered more important in predicting outcomes than chronological 
age. While we do not report any statistical analysis of the respondent’s 
comments explaining their answers, this distinction between physio-
logical and chronological age was the most frequent comment seen. 
Still others pointed out that they decide whether or not to list candi-
dates on a “case by case basis,” without strict protocols. Relatively few 
programs report protocols suggesting absolute age cutoffs for listing 
in the context of specific comorbidities such as cardiovascular disease 
(Figure 2). This overall approach of not excluding candidates purely on 
the basis of age is also consistent with the recommendations of recent 
reviews and guidelines.12
Almost one- third of U.S. programs may try to get at the distinction 
between physiological and chronological age by having listing guide-
lines based on life expectancy without transplant, but the reported 
life- expectancy cutoff varies from 2 to 10 years. Such an approach 
may be conceptually reasonable, but estimating life expectancy is 
challenging in itself. Interestingly, 61% of respondents said they would 
transplant patients even if the expected benefit would only be in qual-
ity, not length of life.
Only 25.4% of our respondents report performing functional 
assessments on all candidates, but most of the other programs will 
perform such assessments if an informal assessment suggests doing 
so. Yet, how to use this information continues to vary significantly 
between programs (Figure 5). Similarly, programs have variable ways 
of using the information that a candidate lives in a nursing home 
(Figure 3) or has cognitive impairment (Figure 4).
Some transplant providers have questioned the advisability of 
using live donors for older recipients. However, we find that the vast 
majority of U.S. programs would accept a live donor for an older re-
cipient, even if that donor were a nondirected donor. In fact, in the 
comments section of the survey, many respondents reported that 
while they would list older candidates, they would often only do so if 
the candidate had a live donor, presumably because of poor expected 
recipient outcomes after prolonged listing for a deceased donor.
This study has all the limitations of any emailed survey. There is 
potential bias in self- reporting practices, although the answers were 
anonymous and it is hard to imagine any pressure on respondents to 
provide answers that are in any way “better” than the reality. There 
is also a potential for respondents’ not being representative of all 
US transplant centers. We did find in the UNOS database the actual 
number of transplants performed in 2012, based on the respondent’s 
reported 4 digit UNOS code and calculated a mean number of trans-
plants of 99.5, somewhat lower than the reported mean of 108.5. 
However, the mean number of transplants performed in nonpediat-
ric programs in the USA in 2012 was 77.2,1 not statistically different 
from the 99.5 mean of respondent programs (P = .11). This suggests 
that, at least based on program size, our respondents were similar 
to all U.S. programs. We also note that those who were 65 or over 
comprised 18.4% of patients transplanted in 2012,1 not far from 
the mean 22.9% of our respondents’ reported waitlist. As we did 
not survey pediatric programs, it is not surprising that the national 
data, which includes pediatric programs, reports a somewhat lower 
percentage	of	≥65-	year-	old	recipients.	Detailed	information	on	the	
percentage	of	≥65-	year-	old	transplants	in	nonpediatric	programs	is	
not available to make a direct comparison to our respondents.
Our findings of variable practice patterns in particular areas, such 
as the impact of cognitive or functional impairments, highlight some 
specific areas that may be particularly fruitful for research. For exam-
ple, the difficulty in estimating physiological age remains, but it may 
be that formal measurements of frailty13 will be helpful additions in 
that assessment. Clearly, further studies are needed regarding the 
F IGURE  6 What other criteria does 
your program use to de- list older potential 
recipients (check all that apply)? n = 59
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impact of age and comorbidities on kidney transplant outcomes, and 
on which older patients are most appropriate for transplant listing.
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